Insight Molecular Diagnostics Inc. (IMDX) stock
IMDXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$1.59−0.19 (-10.67%)
Close on Nov 18, 2026Market cap $52.03MP/E –Yield –
Insight Molecular Diagnostics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Insight Molecular Diagnostics's market cap was $77.97M on Nov 11, 2026, against $175.76M a year earlier. Over the last 5 years it ranged from $18.82M to $214.69M, with a median of $72.07M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $77.97M | -63.7% |
| 2025 | Dec 31, 2025 | $214.69M | +574.5% |
| 2024 | Dec 31, 2024 | $31.83M | +54.1% |
| 2023 | Dec 29, 2023 | $20.65M | -45.7% |
| 2022 | Dec 30, 2022 | $38.06M | -81.0% |
| 2021 | Dec 31, 2021 | $199.98M | +24.4% |
| 2020 | Dec 31, 2020 | $160.73M | +37.4% |
| 2019 | Dec 31, 2019 | $116.94M | +108.4% |
| 2018 | Dec 31, 2018 | $56.12M | -61.6% |
| 2017 | Dec 29, 2017 | $146.09M | -27.7% |
| 2016 | Dec 30, 2016 | $202.17M | +77.7% |
| 2015 | Dec 31, 2015 | $113.75M | – |
See a number that looks wrong?